Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-224867
Filing Date
2012-05-10
Accepted
2012-05-10 13:57:49
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d350137d10q.htm 10-Q 187013
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) d350137dex311.htm EX-31.1 9147
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) d350137dex312.htm EX-31.2 9149
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 d350137dex321.htm EX-32.1 3302
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 d350137dex322.htm EX-32.2 3302
  Complete submission text file 0001193125-12-224867.txt   931272

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT appa-20120331.xml EX-101.INS 69148
7 XBRL TAXONOMY EXTENSION SCHEMA appa-20120331.xsd EX-101.SCH 11171
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appa-20120331_cal.xml EX-101.CAL 14453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appa-20120331_def.xml EX-101.DEF 6686
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE appa-20120331_lab.xml EX-101.LAB 71661
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appa-20120331_pre.xml EX-101.PRE 45637
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 12829398
SIC: 2834 Pharmaceutical Preparations